Literature DB >> 9888125

Cue reactivity and effects of cue exposure in abstinent posttreatment drug users.

I H Franken1, H A de Haan, C W van der Meer, P M Haffmans, V M Hendriks.   

Abstract

After 12 months of inpatient treatment, 16 opiate-addicted patients were exposed to drug-related stimuli. The results of this study indicate that cue reactivity in opiate-addicted subjects is still present after 12 months of intensive inpatient treatment. After exposing subjects to drug-related stimuli, there is an increase in craving, feelings of depression, and anger. Because posttreatment subjects are likely to be confronted with these stimuli following discharge, a reduction of this reactivity is desirable. In the present study, cue reactivity (feelings of depression, anger, tension, craving, and physical symptoms) reduced after protocolized cue exposure treatment. This effect maintained for at least 6 weeks after the last cue exposure session.

Entities:  

Mesh:

Year:  1999        PMID: 9888125     DOI: 10.1016/s0740-5472(98)00004-x

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  26 in total

1.  Neurofeedback Effects on Evoked and Induced EEG Gamma Band Reactivity to Drug-related Cues in Cocaine Addiction.

Authors:  Timothy Horrell; Ayman El-Baz; Joshua Baruth; Allan Tasman; Guela Sokhadze; Christopher Stewart; Estate Sokhadze
Journal:  J Neurother       Date:  2010-07

2.  Advances in neurobiological research related to interventions in adolescents with substance use disorders: research to practice.

Authors:  Paula D Riggs; Laetitia L Thompson; Susan F Tapert; Joseph Frascella; Susan Mikulich-Gilbertson; Manish Dalwani; Mark Laudenslager; Michelle Lohman
Journal:  Drug Alcohol Depend       Date:  2007-12-01       Impact factor: 4.492

3.  Masked smoking-related images modulate brain activity in smokers.

Authors:  Xiaochu Zhang; Xiangchuan Chen; Yongqiang Yu; Delin Sun; Ning Ma; Sheng He; Xiaoping Hu; Daren Zhang
Journal:  Hum Brain Mapp       Date:  2009-03       Impact factor: 5.038

4.  Effects of prior cocaine versus morphine or heroin self-administration on extinction learning driven by overexpectation versus omission of reward.

Authors:  Federica Lucantonio; Sarita Kambhampati; Richard Z Haney; Deniz Atalayer; Neil E Rowland; Yavin Shaham; Geoffrey Schoenbaum
Journal:  Biol Psychiatry       Date:  2014-11-27       Impact factor: 13.382

5.  Environmental cues and relapse: an old idea that is new for reentry of recovering anesthesia care professionals.

Authors:  Heather Wilson
Journal:  Mayo Clin Proc       Date:  2009-11       Impact factor: 7.616

6.  Initial RCT of a distress tolerance treatment for individuals with substance use disorders.

Authors:  Marina A Bornovalova; Kim L Gratz; Stacey B Daughters; Elizabeth D Hunt; C W Lejuez
Journal:  Drug Alcohol Depend       Date:  2011-10-07       Impact factor: 4.492

7.  The role of craving in the treatment of alcohol use disorders: The importance of competing desires and pretreatment changes in drinking.

Authors:  Robert C Schlauch; Cory A Crane; Gerard J Connors; Ronda L Dearing; Stephen A Maisto
Journal:  Drug Alcohol Depend       Date:  2019-04-25       Impact factor: 4.492

8.  Laboratory-induced cue reactivity among individuals with prescription opioid dependence.

Authors:  Sudie E Back; Daniel F Gros; Jenna L McCauley; Julianne C Flanagan; Elizabeth Cox; Kelly S Barth; Kathleen T Brady
Journal:  Addict Behav       Date:  2014-04-12       Impact factor: 3.913

Review 9.  Cued for risk: Evidence for an incentive sensitization framework to explain the interplay between stress and anxiety, substance abuse, and reward uncertainty in disordered gambling behavior.

Authors:  Samantha N Hellberg; Trinity I Russell; Mike J F Robinson
Journal:  Cogn Affect Behav Neurosci       Date:  2019-06       Impact factor: 3.282

10.  Attending to emotional cues for drug abuse: bridging the gap between clinic and home behaviors.

Authors:  Michael W Otto; Conall M O' Cleirigh; Mark H Pollack
Journal:  Sci Pract Perspect       Date:  2007-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.